Neuroinflammation: The role and consequences

Neuroscience Research

Volumn 79, Issue 1, 2014, Pages 1-12

  Lyman, Monty ^a   Lloyd, Dafydd G ^a   Ji, Xunming ^b   Vizcaychipi, Marcela P ^a   Ma, Daqing ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Microglia; Multiple sclerosis; Neuroinflammation; Postoperative cognitive dysfunction; Systemic inflammation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BRADYKININ; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; GAMMA INTERFERON; GLYCOGEN SYNTHASE KINASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE; OCCLUDIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CHEMOTAXIS; COGNITIVE DEFECT; CYTOKINE RELEASE; DELIRIUM; DEMENTIA; DISEASE COURSE; DISEASES; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; POSTOPERATIVE COGNITIVE DYSFUNCTION; PRIORITY JOURNAL; REVIEW; UPREGULATION; MICROGLIA; PROTEIN PHOSPHORYLATION; SYNAPSE;

ALZHEIMER'S DISEASE; MICROGLIA; MULTIPLE SCLEROSIS; NEUROINFLAMMATION; POSTOPERATIVE COGNITIVE DYSFUNCTION; SYSTEMIC INFLAMMATION;

ENCEPHALITIS; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 84896738387     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2013.10.004     Document Type: Review

References (161)

1. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews. Neuroscience 2006, 7:41-53.
2. Aid S., Langenbach R., Bosetti F. Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. Journal of Neuroinflammation 2008, 5:17.
3. Al Nimer F., Beyeen A.D., Lindblom R., Strom M., Aeinehband S., Lidman O., Piehl F. Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury. Brain, Behavior, and Immunity 2011, 25:981-990.
4. Alonso A.C., Grundke-Iqbal I., Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nature Medicine 1996, 2:783-787.
5. Anderson G.D., Hauser S.D., McGarity K.L., Bremer M.E., Isakson P.C., Gregory S.A. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. The Journal of Clinical Investigation 1996, 97:2672-2679.
6. Arfi A., Richard M., Gandolphe C., Bonnefont-Rousselot D., Therond P., Scherman D. Neuroinflammatory and oxidative stress phenomena in MPS IIIA mouse model: the positive effect of long-term aspirin treatment. Molecular Genetics and Metabolism 2011, 103:18-25.
7. Avital A., Goshen I., Kamsler A., Segal M., Iverfeldt K., Richter-Levin G., Yirmiya R. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 2003, 13:826-834.
8. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21:6480-6491.
9. Balschun D., Randolf A., Pitossi F., Schneider H., Del Rey A., Besedovsky H.O. Hippocampal interleukin-1 beta gene expression during long-term potentiation decays with age. Annals of the New York Academy of Sciences 2003, 992:1-8.
10. Bancher C., Brunner C., Lassmann H., Budka H., Jellinger K., Wiche G., Seitelberger F., Grundke-Iqbal I., Iqbal K., Wisniewski H.M. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Research 1989, 477:90-99.
11. Barrientos R.M., Higgins E.A., Biedenkapp J.C., Sprunger D.B., Wright-Hardesty K.J., Watkins L.R., Rudy J.W., Maier S.F. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiology of Aging 2006, 27:723-732.
12. Basselin M., Ramadan E., Chen M., Rapoport S.I. Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. Neurochemical Research 2011, 36:139-145.
13. Belarbi K., Jopson T., Tweedie D., Arellano C., Luo W., Greig N.H., Rosi S. TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. Journal of Neuroinflammation 2012, 9:23.
14. Bernier P.J., Bedard A., Vinet J., Levesque M., Parent A. Newly generated neurons in the amygdala and adjoining cortex of adult primates. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:11464-11469.
15. Beurel E., Jope R.S. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. Journal of Neuroinflammation 2009, 6:9.
16. Bliss T.V., Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. Journal of Physiology 1973, 232:331-356.
17. Breitbart W., Rosenfeld B., Roth A., Smith M.J., Cohen K., Passik S. The Memorial Delirium Assessment Scale. Journal of Pain and Symptom Management 1997, 13:128-137.
18. Breitner J.C., Baker L.D., Montine T.J., Meinert C.L., Lyketsos C.G., Ashe K.H., Brandt J., Craft S., Evans D.E., Green R.C., Ismail M.S., Martin B.K., Mullan M.J., Sabbagh M., Tariot P.N. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2011, 7:402-411.
19. Buchanan J.B., Sparkman N.L., Chen J., Johnson R.W. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology 2008, 33:755-765.
20. Butler M.P., O'Connor J.J., Moynagh P.N. Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 2004, 124:319-326.
21. Butovsky O., Ziv Y., Schwartz A., Landa G., Talpalar A.E., Pluchino S., Martino G., Schwartz M. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Molecular and Cellular Neurosciences 2006, 31:149-160.
22. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358:461-467.
23. Carrero I., Gonzalo M.R., Martin B., Sanz-Anquela J.M., Arevalo-Serrano J., Gonzalo-Ruiz A. Oligomers of beta-amyloid protein (Abeta1-42) induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1beta, tumour necrosis factor-alpha, and a nuclear factor kappa-B mechanism in the rat brain. Experimental Neurology 2012, 236:215-227.
24. Cerejeira J., Nogueira V., Luis P., Vaz-Serra A., Mukaetova-Ladinska E.B. The cholinergic system and inflammation: common pathways in delirium pathophysiology. Journal of the American Geriatrics Society 2012, 60:669-675.
25. Chen C.H., Zhou W., Liu S., Deng Y., Cai F., Tone M., Tone Y., Tong Y., Song W. Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease. International Journal of Neuropsychopharmacology 2011, 1-14.
26. Chen J., Buchanan J.B., Sparkman N.L., Godbout J.P., Freund G.G., Johnson R.W. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain, Behavior, and Immunity 2008, 22:301-311.
27. Cibelli M., Fidalgo A.R., Terrando N., Ma D., Monaco C., Feldmann M., Takata M., Lever I.J., Nanchahal J., Fanselow M.S., Maze M. Role of interleukin-1beta in postoperative cognitive dysfunction. Annals of Neurology 2010, 68:360-368.
28. Cirrito J.R., Yamada K.A., Finn M.B., Sloviter R.S., Bales K.R., May P.C., Schoepp D.D., Paul S.M., Mennerick S., Holtzman D.M. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 2005, 48:913-922.
29. Cowley T.R., Fahey B., O'Mara S.M. COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivo. The European Journal of Neuroscience 2008, 27:2999-3008.
30. Craig-Schapiro R., Perrin R.J., Roe C.M., Xiong C., Carter D., Cairns N.J., Mintun M.A., Peskind E.R., Li G., Galasko D.R., Clark C.M., Quinn J.F., D'Angelo G., Malone J.P., Townsend R.R., Morris J.C., Fagan A.M., Holtzman D.M. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biological Psychiatry 2010, 68:903-912.
31. Culbert A.A., Skaper S.D., Howlett D.R., Evans N.A., Facci L., Soden P.E., Seymour Z.M., Guillot F., Gaestel M., Richardson J.C. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. The Journal of Biological Chemistry 2006, 281:23658-23667.
32. Cumiskey D., Curran B.P., Herron C.E., O'Connor J.J. A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus. Neuropharmacology 2007, 52:1616-1623.
33. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neuroscience Letters 1996, 203:17-20.
34. Cunningham C., Campion S., Lunnon K., Murray C.L., Woods J.F., Deacon R.M., Rawlins J.N., Perry V.H. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biological Psychiatry 2009, 65:304-312.
35. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:9275-9284.
36. de Vries H.E., Blom-Roosemalen M.C., van Oosten M., de Boer A.G., van Berkel T.J., Breimer D.D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. Journal of Neuroimmunology 1996, 64:37-43.
37. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., Welch D., Manness L., Lin C., Yu J., Zhu H., Ghiso J., Frangione B., Stern A., Schmidt A.M., Armstrong D.L., Arnold B., Liliensiek B., Nawroth P., Hofman F., Kindy M., Stern D., Zlokovic B. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nature Medicine 2003, 9:907-913.
38. DiCarlo G., Wilcock D., Henderson D., Gordon M., Morgan D. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. Neurobiology of Aging 2001, 22:1007-1012.
39. Eikelenboom P., Veerhuis R. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiology of Aging 1996, 17:673-680.
40. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:13632-13637.
41. Engelhardt.B. T cell migration into the central nervous system during health and disease: different molecular keys allow access to different central nervous system compartments. Clinical and Experimental Neuroimmunology 2010, 1:79-93.
42. Faissner A., Pyka M., Geissler M., Sobik T., Frischknecht R., Gundelfinger E.D., Seidenbecher C. Contributions of astrocytes to synapse formation and maturation - potential functions of the perisynaptic extracellular matrix. Brain Research Reviews 2010, 63:26-38.
43. Fernandes-Alnemri T., Yu J.W., Datta P., Wu J., Alnemri E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009, 458:509-513.
44. Fiala M., Liu Q.N., Sayre J., Pop V., Brahmandam V., Graves M.C., Vinters H.V. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. European Journal of Clinical Investigation 2002, 32:360-371.
45. Folks D.G., Freeman A.M., Sokol R.S., Govier A.V., Reves J.G., Baker D.M. Cognitive dysfunction after coronary artery bypass surgery: a case-controlled study. Southern Medical Journal 1988, 81:202-206.
46. Frank M.G., Baratta M.V., Sprunger D.B., Watkins L.R., Maier S.F. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain, Behavior, and Immunity 2007, 21:47-59.
47. Frank M.G., Thompson B.M., Watkins L.R., Maier S.F. Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain, Behavior, and Immunity 2012, 26:337-345.
48. Fransson M.E., Liljenfeldt L.S., Fagius J., Totterman T.H., Loskog A.S. The T-cell pool is anergized in patients with multiple sclerosis in remission. Immunology 2009, 126:92-101.
49. Fung A., Vizcaychipi M., Lloyd D., Wan Y., Ma D. Central nervous system inflammation in disease related conditions: mechanistic prospects. Brain Research 2012, 1446:144-155.
50. Gabbita S.P., Srivastava M.K., Eslami P., Johnson M.F., Kobritz N.K., Tweedie D., Greig N.H., Zemlan F.P., Sharma S.P., Harris-White M.E. Early intervention with a small molecule inhibitor for tumor necrosis factor-alpha prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease. Journal of Neuroinflammation 2012, 9:99.
51. Ghosal K., Vogt D.L., Liang M., Shen Y., Lamb B.T., Pimplikar S.W. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:18367-18372.
52. Gibertini M., Newton C., Friedman H., Klein T.W. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain, Behavior, and Immunity 1995, 9:113-128.
53. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nature Medicine 1999, 5:698-701.
54. Goehler L.E., Gaykema R.P., Nguyen K.T., Lee J.E., Tilders F.J., Maier S.F., Watkins L.R. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems?. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1999, 19:2799-2806.
55. Green H.F., Nolan Y.M. GSK-3 mediates the release of IL-1beta, TNF-alpha and IL-10 from cortical glia. Neurochemistry International 2012, 61:666-671.
56. Gutierrez E.G., Banks W.A., Kastin A.J. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. Journal of Neuroimmunology 1993, 47:169-176.
57. Hamberg M., Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 1973, 70:899-903.
58. Harry G.J., Lefebvre d'Hellencourt C., McPherson C.A., Funk J.A., Aoyama M., Wine R.N. Tumor necrosis factor p55 and p75 receptors are involved in chemical-induced apoptosis of dentate granule neurons. Journal of Neurochemistry 2008, 106:281-298.
59. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. The New England Journal of Medicine 2008, 358:676-688.
60. Herber D.L., Roth L.M., Wilson D., Wilson N., Mason J.E., Morgan D., Gordon M.N. Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. Experimental Neurology 2004, 190:245-253.
61. Hohmann H.P., Brockhaus M., Baeuerle P.A., Remy R., Kolbeck R., van Loon A.P. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. The Journal of Biological Chemistry 1990, 265:22409-22417.
62. Hoozemans J.J., Rozemuller A.J., Janssen I., De Groot C.J., Veerhuis R., Eikelenboom P. Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathologica 2001, 101:2-8.
63. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. Journal of Immunology 1999, 162:3749-3752.
64. Hu J., Akama K.T., Krafft G.A., Chromy B.A., Van Eldik L.J. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Research 1998, 785:195-206.
65. Huang W.C., Lin Y.S., Wang C.Y., Tsai C.C., Tseng H.C., Chen C.L., Lu P.J., Chen P.S., Qian L., Hong J.S., Lin C.F. Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells. Immunology 2009, 128:e275-e286.
66. Ifergan I., Wosik K., Cayrol R., Kebir H., Auger C., Bernard M., Bouthillier A., Moumdjian R., Duquette P., Prat A. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Annals of Neurology 2006, 60:45-55.
67. Jaeger L.B., Dohgu S., Sultana R., Lynch J.L., Owen J.B., Erickson M.A., Shah G.N., Price T.O., Fleegal-Demotta M.A., Butterfield D.A., Banks W.A. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain, Behavior, and Immunity 2009, 23:507-517.
68. Jana M., Palencia C.A., Pahan K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. Journal of Immunology 2008, 181:7254-7262.
69. Jaturapatporn D., Isaac M.G., McCleery J., Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. Cochrane Database of Systematic Reviews 2012, 2:CD006378.
70. Jung Y.D., Fan F., McConkey D.J., Jean M.E., Liu W., Reinmuth N., Stoeltzing O., Ahmad S.A., Parikh A.A., Mukaida N., Ellis L.M. Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1beta-induced IL-8 expression in human vascular smooth muscle cells. Cytokine 2002, 18:206-213.
71. Kalman J., Juhasz A., Bogats G., Babik B., Rimanoczy A., Janka Z., Penke B., Palotas A. Elevated levels of inflammatory biomarkers in the cerebrospinal fluid after coronary artery bypass surgery are predictors of cognitive decline. Neurochemistry International 2006, 48:177-180.
72. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron 2003, 37:925-937.
73. Katznelson R., Djaiani G.N., Borger M.A., Friedman Z., Abbey S.E., Fedorko L., Karski J., Mitsakakis N., Carroll J., Beattie W.S. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology 2009, 110:67-73.
74. Kipp M., Norkute A., Johann S., Lorenz L., Braun A., Hieble A., Gingele S., Pott F., Richter J., Beyer C. Brain-region-specific astroglial responses in vitro after LPS exposure. Journal of Molecular Neuroscience: MN 2008, 35:235-243.
75. Kischkel F.C., Lawrence D.A., Chuntharapai A., Schow P., Kim K.J., Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000, 12:611-620.
76. Kitazawa M., Oddo S., Yamasaki T.R., Green K.N., LaFerla F.M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:8843-8853.
77. Koller H., Trimborn M., von Giesen H., Schroeter M., Arendt G. TNFalpha reduces glutamate induced intracellular Ca(2+) increase in cultured cortical astrocytes. Brain Research 2001, 893:237-243.
78. Kotilinek L.A., Westerman M.A., Wang Q., Panizzon K., Lim G.P., Simonyi A., Lesne S., Falinska A., Younkin L.H., Younkin S.G., Rowan M., Cleary J., Wallis R.A., Sun G.Y., Cole G., Frautschy S., Anwyl R., Ashe K.H. Cyclooxygenase-2 inhibition improves amyloid-beta-mediated suppression of memory and synaptic plasticity. Brain: A Journal of Neurology 2008, 131:651-664.
79. Krstic D., Madhusudan A., Doehner J., Vogel P., Notter T., Imhof C., Manalastas A., Hilfiker M., Pfister S., Schwerdel C., Riether C., Meyer U., Knuesel I. Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. Journal of Neuroinflammation 2012, 9:151.
80. Kuhn H.G., Dickinson-Anson H., Gage F.H. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1996, 16:2027-2033.
81. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. Journal of Neurochemistry 1998, 70:452-466.
82. Laflamme N., Lacroix S., Rivest S. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 1999, 19:10923-10930.
83. Lauro C., Cipriani R., Catalano M., Trettel F., Chece G., Brusadin V., Antonilli L., van Rooijen N., Eusebi F., Fredholm B.B., Limatola C. Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology 2010, 35:1550-1559.
84. Lee D.C., Rizer J., Selenica M.L., Reid P., Kraft C., Johnson A., Blair L., Gordon M.N., Dickey C.A., Morgan D. LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. Journal of Neuroinflammation 2010, 7:56.
85. Lee M., Sparatore A., Del Soldato P., McGeer E., McGeer P.L. Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation. Glia 2010, 58:103-113.
86. Li B., Mahmood A., Lu D., Wu H., Xiong Y., Qu C., Chopp M. Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury. Neurosurgery 2009, 65:179-185. (discussion 185-176).
87. Li Y., Liu L., Barger S.W., Griffin W.S. Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2003, 23:1605-1611.
88. Liao Y.F., Wang B.J., Cheng H.T., Kuo L.H., Wolfe M.S. Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. The Journal of Biological Chemistry 2004, 279:49523-49532.
89. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. The Journal of Pharmacology and Experimental Therapeutics 2003, 304:1-7.
90. Liu X., Wu Z., Hayashi Y., Nakanishi H. Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation. Neuroscience 2012, 216:133-142.
91. Liu Y.P., Lin H.I., Tzeng S.F. Tumor necrosis factor-alpha and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture. Brain Research 2005, 1054:152-158.
92. Mander P., Brown G.C. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. Journal of Neuroinflammation 2005, 2:20.
93. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature Immunology 2005, 6:777-784.
94. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L.A., McKeel D.W., Morris J.C. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 2001, 56:127-129.
95. Matousek S.B., Hein A.M., Shaftel S.S., Olschowka J.A., Kyrkanides S., O'Banion M.K. Cyclooxygenase-1 mediates prostaglandin E(2) elevation and contextual memory impairment in a model of sustained hippocampal interleukin-1beta expression. Journal of Neurochemistry 2010, 114:247-258.
96. Medeiros R., Figueiredo C.P., Pandolfo P., Duarte F.S., Prediger R.D., Passos G.F., Calixto J.B. The role of TNF-alpha signaling pathway on COX-2 upregulation and cognitive decline induced by beta-amyloid peptide. Behavioural Brain Research 2010, 209:165-173.
97. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
98. Mishra A., Kim H.J., Shin A.H., Thayer S.A. Synapse loss induced by interleukin-1beta requires pre- and post-synaptic mechanisms. Journal of NeuroImmune Pharmacology 2012, 7:571-578.
99. Moller J.T., Cluitmans P., Rasmussen L.S., Houx P., Rasmussen H., Canet J., Rabbitt P., Jolles J., Larsen K., Hanning C.D., Langeron O., Johnson T., Lauven P.M., Kristensen P.A., Biedler A., van Beem H., Fraidakis O., Silverstein J.H., Beneken J.E., Gravenstein J.S. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998, 351:857-861.
100. Moreno B., Jukes J.P., Vergara-Irigaray N., Errea O., Villoslada P., Perry V.H., Newman T.A. Systemic inflammation induces axon injury during brain inflammation. Annals of Neurology 2011, 70:932-942.
101. Morris R.G., Garrud P., Rawlins J.N., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982, 297:681-683.
102. Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M., Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2000, 20:4050-4058.
103. Munster B.C., Aronica E., Zwinderman A.H., Eikelenboom P., Cunningham C., Rooij S.E. Neuroinflammation in delirium: a postmortem case-control study. Rejuvenation Research 2011, 14:615-622.
104. Murray C., Sanderson D.J., Barkus C., Deacon R.M., Rawlins J.N., Bannerman D.M., Cunningham C. Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiology of Aging 2012, 33:603-616. e603.
105. Nestel F.P., Price K.S., Seemayer T.A., Lapp W.S. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. The Journal of Experimental Medicine 1992, 175:405-413.
106. Niessner A., Steiner S., Speidl W.S., Pleiner J., Seidinger D., Maurer G., Goronzy J.J., Weyand C.M., Kopp C.W., Huber K., Wolzt M., Wojta J. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 2006, 189:408-413.
107. Nitsch R., Bechmann I., Deisz R.A., Haas D., Lehmann T.N., Wendling U., Zipp F. Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 2000, 356:827-828.
108. O'Donnell E., Vereker E., Lynch M.A. Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. The European Journal of Neuroscience 2000, 12:345-352.
109. Opal S.M., DePalo V.A. Anti-inflammatory cytokines. Chest 2000, 117:1162-1172.
110. Pahan K., Sheikh F.G., Namboodiri A.M., Singh I. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. The Journal of Clinical Investigation 1997, 100:2671-2679.
111. Parolari A., Camera M., Alamanni F., Naliato M., Polvani G.L., Agrifoglio M., Brambilla M., Biancardi C., Mussoni L., Biglioli P., Tremoli E. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. The Annals of Thoracic Surgery 2007, 84:823-828.
112. Pearson H.A., Peers C. Physiological roles for amyloid beta peptides. Journal of Physiology 2006, 575:5-10.
113. Pflanzner T., Janko M.C., Andre-Dohmen B., Reuss S., Weggen S., Roebroek A.J., Kuhlmann C.R., Pietrzik C.U. LRP1 mediates bidirectional transcytosis of amyloid-beta across the blood-brain barrier. Neurobiology of Aging 2011, 32(232):e2311-e2321.
114. Phiel C.J., Wilson C.A., Lee V.M., Klein P.S. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003, 423:435-439.
115. Pittock S.J., Lennon V.A., McKeon A., Mandrekar J., Weinshenker B.G., Lucchinetti C.F., O'Toole O., Wingerchuk D.M. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. The Lancet Neurology 2013, 12:554-562.
116. Quan N., Stern E.L., Whiteside M.B., Herkenham M. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. Journal of Neuroimmunology 1999, 93:72-80.
117. Quintanilla R.A., Orellana D.I., Gonzalez-Billault C., Maccioni R.B. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Experimental Cell Research 2004, 295:245-257.
118. Ramirez S.H., Fan S., Zhang M., Papugani A., Reichenbach N., Dykstra H., Mercer A.J., Tuma R.F., Persidsky Y. Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells. The American Journal of Pathology 2010, 176:881-892.
119. Ramlawi B., Rudolph J.L., Mieno S., Feng J., Boodhwani M., Khabbaz K., Levkoff S.E., Marcantonio E.R., Bianchi C., Sellke F.W. C-Reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery. Surgery 2006, 140:221-226.
120. Rees K., Stowe R., Patel S., Ives N., Breen K., Clarke C.E., Ben-Shlomo Y. Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies. Cochrane Database of Systematic Reviews 2011, CD008454.
121. Ricoy U.M., Mao P., Manczak M., Reddy P.H., Frerking M.E. A transgenic mouse model for Alzheimer's disease has impaired synaptic gain but normal synaptic dynamics. Neuroscience Letters 2011, 500:212-215.
122. Ridley S.H., Sarsfield S.J., Lee J.C., Bigg H.F., Cawston T.E., Taylor D.J., DeWitt D.L., Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. Journal of Immunology 1997, 158:3165-3173.
123. Ringheim G.E., Szczepanik A.M., Petko W., Burgher K.L., Zhu S.Z., Chao C.C. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. Brain Research. Molecular Brain Research 1998, 55:35-44.
124. Rolls A., Shechter R., London A., Ziv Y., Ronen A., Levy R., Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nature Cell Biology 2007, 9:1081-1088.
125. Rosczyk H.A., Sparkman N.L., Johnson R.W. Neuroinflammation and cognitive function in aged mice following minor surgery. Experimental Gerontology 2008, 43:840-846.
126. Rudolph J.L., Marcantonio E.R., Culley D.J., Silverstein J.H., Rasmussen L.S., Crosby G.J., Inouye S.K. Delirium is associated with early postoperative cognitive dysfunction. Anaesthesia 2008, 63:941-947.
127. Rudolph J.L., Ramlawi B., Kuchel G.A., McElhaney J.E., Xie D., Sellke F.W., Khabbaz K., Levkoff S.E., Marcantonio E.R. Chemokines are associated with delirium after cardiac surgery. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2008, 63:184-189.
128. Saadoun S., Waters P., Bell B.A., Vincent A., Verkman A.S., Papadopoulos M.C. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain: A Journal of Neurology 2010, 133:349-361.
129. Saez T.E., Pehar M., Vargas M., Barbeito L., Maccioni R.B. Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons. In Vivo 2004, 18:275-280.
130. Schilling T., Eder C. Amyloid-beta-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia. Journal of Cellular Physiology 2011, 226:3295-3302.
131. Schwab J.M., Beschorner R., Meyermann R., Gozalan F., Schluesener H.J. Persistent accumulation of cyclooxygenase-1-expressing microglial cells and macrophages and transient upregulation by endothelium in human brain injury. Journal of Neurosurgery 2002, 96:892-899.
132. Schwaninger M., Sallmann S., Petersen N., Schneider A., Prinz S., Libermann T.A., Spranger M. Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB. Journal of Neurochemistry 1999, 73:1461-1466.
133. Shaw L.M., Vanderstichele H., Knapik-Czajka M., Clark C.M., Aisen P.S., Petersen R.C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V.M., Trojanowski J.Q. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology 2009, 65:403-413.
134. Shaw P.J., Bates D., Cartlidge N.E., French J.M., Heaviside D., Julian D.G., Shaw D.A. Early intellectual dysfunction following coronary bypass surgery. Quarterly Journal of Medicine 1986, 58:59-68.
135. Smits H.A., Rijsmus A., van Loon J.H., Wat J.W., Verhoef J., Boven L.A., Nottet H.S. Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. Journal of Neuroimmunology 2002, 127:160-168.
136. Sokolova A., Hill M.D., Rahimi F., Warden L.A., Halliday G.M., Shepherd C.E. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathology 2009, 19:392-398.
137. Stalder A.K., Ermini F., Bondolfi L., Krenger W., Burbach G.J., Deller T., Coomaraswamy J., Staufenbiel M., Landmann R., Jucker M. Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2005, 25:11125-11132.
138. Stark D.T., Bazan N.G. Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2011, 31:13710-13721.
139. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440:1054-1059.
140. Sung S., Yang H., Uryu K., Lee E.B., Zhao L., Shineman D., Trojanowski J.Q., Lee V.M., Pratico D. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. The American Journal of Pathology 2004, 165:2197-2206.
141. Tan Z.S., Beiser A.S., Vasan R.S., Roubenoff R., Dinarello C.A., Harris T.B., Benjamin E.J., Au R., Kiel D.P., Wolf P.A., Seshadri S. Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology 2007, 68:1902-1908.
142. Terblanche M., Almog Y., Rosenson R.S., Smith T.S., Hackam D.G. Statins and sepsis: multiple modifications at multiple levels. Lancet Infectious Diseases 2007, 7:358-368.
143. Terrando N., Eriksson L.I., Ryu J.K., Yang T., Monaco C., Feldmann M., Jonsson Fagerlund M., Charo I.F., Akassoglou K., Maze M. Resolving postoperative neuroinflammation and cognitive decline. Annals of Neurology 2011, 70:986-995.
144. Thomson L.M., Sutherland R.J. Systemic administration of lipopolysaccharide and interleukin-1beta have different effects on memory consolidation. Brain Research Bulletin 2005, 67:24-29.
145. Townsend K.P., Shytle D.R., Bai Y., San N., Zeng J., Freeman M., Mori T., Fernandez F., Morgan D., Sanberg P., Tan J. Lovastatin modulation of microglial activation via suppression of functional CD40 expression. Journal of Neuroscience Research 2004, 78:167-176.
146. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. The American Journal of Pathology 2008, 172:146-155.
147. Vereker E., Campbell V., Roche E., McEntee E., Lynch M.A. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. The Journal of Biological Chemistry 2000, 275:26252-26258.
148. Vinet J., Weering H.R., Heinrich A., Kalin R.E., Wegner A., Brouwer N., Heppner F.L., Rooijen N., Boddeke H.W., Biber K. Neuroprotective function for ramified microglia in hippocampal excitotoxicity. Journal of Neuroinflammation 2012, 9:27.
149. Vizcaychipi M.P., Watts H.R., O'Dea K.P., Lloyd D.G., Penn J., Wan Y., Pac-Soo C., Takata M., Ma D. The therapeutic potential of atorvastatin in a mouse model of postoperative cognitive decline. Annals of Surgery 2013, [Epub ahead of print].
150. Vukic V., Callaghan D., Walker D., Lue L.F., Liu Q.Y., Couraud P.O., Romero I.A., Weksler B., Stanimirovic D.B., Zhang W. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiology of Disease 2009, 34:95-106.
151. Waiczies S., Bendix I., Prozorovski T., Ratner M., Nazarenko I., Pfueller C.F., Brandt A.U., Herz J., Brocke S., Ullrich O., Zipp F. Geranylgeranylation but not GTP loading determines rho migratory function in T cells. Journal of Immunology 2007, 179:6024-6032.
152. Wan Y., Xu J., Ma D., Zeng Y., Cibelli M., Maze M. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 2007, 106:436-443.
153. Wang H., Hitron I.M., Iadecola C., Pickel V.M. Synaptic and vascular associations of neurons containing cyclooxygenase-2 and nitric oxide synthase in rat somatosensory cortex. Cerebral Cortex 2005, 15:1250-1260.
154. Wang M.J., Huang H.Y., Chen W.F., Chang H.F., Kuo J.S. Glycogen synthase kinase-3beta inactivation inhibits tumor necrosis factor-alpha production in microglia by modulating nuclear factor kappaB and MLK3/JNK signaling cascades. Journal of Neuroinflammation 2010, 7:99.
155. Warren H.S., Fitting C., Hoff E., Adib-Conquy M., Beasley-Topliffe L., Tesini B., Liang X., Valentine C., Hellman J., Hayden D., Cavaillon J.M. Resilience to bacterial infection: difference between species could be due to proteins in serum. The Journal of Infectious Diseases 2010, 201:223-232.
156. Wong D., Dorovini-Zis K., Vincent S.R. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Experimental Neurology 2004, 190:446-455.
157. Wu Y., Zhai H., Wang Y., Li L., Wu J., Wang F., Sun S., Yao S., Shang Y. Aspirin-triggered lipoxin A(4) attenuates lipopolysaccharide-induced intracellular ROS in BV2 microglia cells by inhibiting the function of NADPH oxidase. Neurochemical Research 2012, 37:1690-1696.
158. Xing B., Bachstetter A.D., Eldik L.J. Microglial p38alpha MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFalpha. Molecular Neurodegeneration 2011, 6:84.
159. Xuan A., Long D., Li J., Ji W., Zhang M., Hong L., Liu J. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease. Journal of Neuroinflammation 2012, 9:202.
160. Yoshiyama Y., Higuchi M., Zhang B., Huang S.M., Iwata N., Saido T.C., Maeda J., Suhara T., Trojanowski J.Q., Lee V.M. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 53:337-351.
161. Yuskaitis C.J., Jope R.S. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cellular Signalling 2009, 21:264-273.